On Monday, July 13, 2020 at 4 PM Eastern Time, the Institute for Gene Therapies (IGT) will host a conversation with recognized experts who will share perspectives on the CMS proposed rule that makes changes to the Medicaid Drug Rebate Program (MDRP) to facilitate value-based purchasing (VBP) arrangements.
Former Congressman and IGT Chairman Erik Paulsen will moderate the discussion to shed light on the proposed rule and its implications for patients, payers and manufacturers, particularly as it relates to transformative gene therapies. Speakers include:
Stuart Portman | Health Policy Advisor, U.S. Senate Finance Committee
Annie Kennedy | Chief of Policy and Advocacy, EveryLife Foundation
Mark Trusheim, MSc | Strategic Director, MIT NEWDIGS
Thomas Evegan | Vice President of Integrichain
Lauren Randall Buckley | Director of Health Policy & Advocacy of IGT
For more information, and to register for this event, click here.